Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Fractures | 19 | 2021 | 75 | 5.900 |
Why?
|
Bone Density | 30 | 2023 | 209 | 5.130 |
Why?
|
Absorptiometry, Photon | 26 | 2022 | 99 | 5.060 |
Why?
|
Osteoporosis | 15 | 2022 | 121 | 4.700 |
Why?
|
Osteoporotic Fractures | 8 | 2023 | 38 | 4.470 |
Why?
|
Hypoparathyroidism | 12 | 2022 | 22 | 4.040 |
Why?
|
Cancellous Bone | 6 | 2022 | 15 | 3.420 |
Why?
|
Parathyroid Hormone | 13 | 2022 | 218 | 2.790 |
Why?
|
Lumbar Vertebrae | 11 | 2021 | 148 | 1.950 |
Why?
|
Hormone Replacement Therapy | 8 | 2022 | 77 | 1.940 |
Why?
|
Calcaneus | 6 | 2013 | 34 | 1.790 |
Why?
|
Hip Fractures | 3 | 2023 | 45 | 1.750 |
Why?
|
Body Composition | 3 | 2022 | 68 | 1.590 |
Why?
|
Quality of Life | 6 | 2022 | 1575 | 1.190 |
Why?
|
Fractures, Bone | 4 | 2021 | 131 | 1.180 |
Why?
|
Vitamin D | 12 | 2022 | 261 | 1.180 |
Why?
|
Femur Neck | 9 | 2022 | 44 | 0.980 |
Why?
|
Osteoporosis, Postmenopausal | 6 | 2014 | 34 | 0.970 |
Why?
|
Diabetes Mellitus | 2 | 2020 | 801 | 0.860 |
Why?
|
Densitometry | 4 | 2015 | 29 | 0.840 |
Why?
|
Diabetes Complications | 2 | 2020 | 206 | 0.830 |
Why?
|
Spine | 3 | 2017 | 102 | 0.800 |
Why?
|
Women's Health | 1 | 2022 | 100 | 0.780 |
Why?
|
Female | 43 | 2023 | 44405 | 0.770 |
Why?
|
Aged | 30 | 2022 | 18353 | 0.770 |
Why?
|
Middle Aged | 31 | 2022 | 24957 | 0.770 |
Why?
|
Nutrition Surveys | 5 | 2022 | 114 | 0.750 |
Why?
|
Bone Diseases, Metabolic | 1 | 2020 | 32 | 0.740 |
Why?
|
Humans | 61 | 2023 | 86281 | 0.720 |
Why?
|
Wrist Injuries | 1 | 2019 | 14 | 0.720 |
Why?
|
Humeral Fractures | 1 | 2019 | 16 | 0.720 |
Why?
|
Accelerometry | 1 | 2019 | 36 | 0.670 |
Why?
|
Calcium | 11 | 2022 | 1148 | 0.670 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 384 | 0.660 |
Why?
|
Femur | 2 | 2017 | 116 | 0.650 |
Why?
|
Male | 33 | 2023 | 40860 | 0.630 |
Why?
|
Body Fat Distribution | 1 | 2017 | 13 | 0.630 |
Why?
|
Recombinant Proteins | 6 | 2021 | 1014 | 0.620 |
Why?
|
Whole Body Imaging | 1 | 2017 | 41 | 0.610 |
Why?
|
Risk Assessment | 9 | 2023 | 2253 | 0.590 |
Why?
|
Societies, Medical | 4 | 2015 | 572 | 0.570 |
Why?
|
Exercise | 1 | 2019 | 315 | 0.540 |
Why?
|
Aged, 80 and over | 14 | 2018 | 6481 | 0.530 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 2594 | 0.510 |
Why?
|
Adult | 22 | 2022 | 25577 | 0.510 |
Why?
|
Thoracic Vertebrae | 3 | 2016 | 49 | 0.480 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 1610 | 0.430 |
Why?
|
Retrospective Studies | 9 | 2023 | 8431 | 0.420 |
Why?
|
Heart Transplantation | 1 | 2016 | 705 | 0.390 |
Why?
|
Glucocorticoids | 5 | 2016 | 347 | 0.380 |
Why?
|
Diabetes Insipidus | 2 | 2006 | 17 | 0.370 |
Why?
|
Hip Joint | 3 | 2018 | 55 | 0.370 |
Why?
|
Patient Selection | 2 | 2014 | 685 | 0.370 |
Why?
|
Pennsylvania | 2 | 2020 | 75 | 0.370 |
Why?
|
Vitamin D Deficiency | 2 | 2021 | 103 | 0.360 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 3 | 2007 | 464 | 0.340 |
Why?
|
Frail Elderly | 1 | 2009 | 71 | 0.330 |
Why?
|
Risk Factors | 9 | 2023 | 5397 | 0.320 |
Why?
|
Incidence | 3 | 2021 | 1568 | 0.300 |
Why?
|
Body Mass Index | 3 | 2022 | 770 | 0.300 |
Why?
|
Radiography | 4 | 2015 | 812 | 0.280 |
Why?
|
Prevalence | 4 | 2016 | 1239 | 0.270 |
Why?
|
Vasopressins | 4 | 1988 | 49 | 0.260 |
Why?
|
Predictive Value of Tests | 5 | 2017 | 1671 | 0.260 |
Why?
|
Calcitriol | 3 | 2020 | 174 | 0.250 |
Why?
|
Double-Blind Method | 5 | 2022 | 1822 | 0.240 |
Why?
|
Treatment Outcome | 8 | 2022 | 7949 | 0.240 |
Why?
|
Calcium, Dietary | 2 | 2022 | 63 | 0.240 |
Why?
|
Bone Matrix | 1 | 2003 | 18 | 0.230 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2022 | 12 | 0.220 |
Why?
|
Age Factors | 3 | 2016 | 1842 | 0.220 |
Why?
|
Bone Density Conservation Agents | 1 | 2022 | 45 | 0.210 |
Why?
|
Bone and Bones | 1 | 2003 | 264 | 0.210 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2017 | 1200 | 0.190 |
Why?
|
Thirst | 3 | 1988 | 19 | 0.180 |
Why?
|
Electronic Health Records | 1 | 2023 | 319 | 0.180 |
Why?
|
Comorbidity | 2 | 2021 | 943 | 0.180 |
Why?
|
Abdomen | 1 | 2020 | 121 | 0.180 |
Why?
|
Logistic Models | 3 | 2010 | 1184 | 0.170 |
Why?
|
Water-Electrolyte Balance | 3 | 2006 | 66 | 0.170 |
Why?
|
Pelvic Bones | 1 | 2019 | 44 | 0.170 |
Why?
|
Chronic Disease | 2 | 2021 | 968 | 0.160 |
Why?
|
United States | 4 | 2020 | 6637 | 0.160 |
Why?
|
Mexican Americans | 1 | 2018 | 63 | 0.160 |
Why?
|
Risk | 1 | 2019 | 673 | 0.160 |
Why?
|
Registries | 1 | 2021 | 702 | 0.160 |
Why?
|
Hip | 1 | 2017 | 18 | 0.160 |
Why?
|
Hypocalcemia | 1 | 2017 | 41 | 0.150 |
Why?
|
Hyperphosphatemia | 1 | 2017 | 20 | 0.150 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 1030 | 0.150 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 1168 | 0.150 |
Why?
|
Osteocalcin | 1 | 2016 | 26 | 0.150 |
Why?
|
Alkaline Phosphatase | 1 | 2016 | 132 | 0.140 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2016 | 41 | 0.140 |
Why?
|
Parathyroidectomy | 1 | 2016 | 78 | 0.140 |
Why?
|
Acetabulum | 1 | 2016 | 28 | 0.140 |
Why?
|
Chicago | 2 | 2021 | 1377 | 0.140 |
Why?
|
Phosphates | 1 | 2016 | 159 | 0.140 |
Why?
|
Prednisone | 1 | 2016 | 255 | 0.140 |
Why?
|
Disability Evaluation | 1 | 2016 | 136 | 0.140 |
Why?
|
Follow-Up Studies | 2 | 2020 | 3616 | 0.140 |
Why?
|
Sensitivity and Specificity | 6 | 2008 | 1987 | 0.130 |
Why?
|
Health Status | 1 | 2018 | 360 | 0.130 |
Why?
|
Artifacts | 1 | 2017 | 244 | 0.130 |
Why?
|
Obesity | 1 | 2022 | 962 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
Severity of Illness Index | 2 | 2017 | 1796 | 0.130 |
Why?
|
Pandemics | 1 | 2020 | 739 | 0.120 |
Why?
|
Physicians | 1 | 2021 | 672 | 0.120 |
Why?
|
Autoimmune Diseases | 1 | 2016 | 241 | 0.120 |
Why?
|
Prognosis | 1 | 2020 | 3669 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2013 | 162 | 0.110 |
Why?
|
Radiographic Image Enhancement | 2 | 2004 | 462 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 1 | 2003 | 3347 | 0.100 |
Why?
|
Homeostasis | 2 | 2016 | 408 | 0.090 |
Why?
|
Anthropometry | 1 | 2010 | 74 | 0.090 |
Why?
|
Body Height | 1 | 2010 | 99 | 0.090 |
Why?
|
Age Distribution | 1 | 2010 | 204 | 0.090 |
Why?
|
Adipogenesis | 1 | 2009 | 38 | 0.090 |
Why?
|
Pluripotent Stem Cells | 1 | 2009 | 31 | 0.090 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 59 | 0.090 |
Why?
|
Mass Screening | 1 | 2013 | 615 | 0.080 |
Why?
|
Water-Electrolyte Imbalance | 1 | 1988 | 14 | 0.080 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2009 | 126 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2009 | 269 | 0.080 |
Why?
|
Menstrual Cycle | 1 | 1988 | 53 | 0.080 |
Why?
|
Activities of Daily Living | 1 | 2009 | 202 | 0.080 |
Why?
|
Illinois | 1 | 2009 | 461 | 0.080 |
Why?
|
Osteogenesis | 1 | 2009 | 241 | 0.080 |
Why?
|
Equipment Failure Analysis | 2 | 2004 | 90 | 0.080 |
Why?
|
Body Water | 1 | 1987 | 35 | 0.070 |
Why?
|
Parathyroid Glands | 2 | 2017 | 74 | 0.070 |
Why?
|
Fractals | 1 | 2006 | 42 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2007 | 2699 | 0.070 |
Why?
|
Antibodies | 1 | 1988 | 349 | 0.070 |
Why?
|
Estrogens | 2 | 2001 | 197 | 0.060 |
Why?
|
Camurati-Engelmann Syndrome | 1 | 2004 | 1 | 0.060 |
Why?
|
Jaw Abnormalities | 1 | 2004 | 1 | 0.060 |
Why?
|
Decision Making | 1 | 2010 | 641 | 0.060 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2004 | 106 | 0.060 |
Why?
|
Area Under Curve | 1 | 2005 | 334 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 362 | 0.060 |
Why?
|
Minerals | 1 | 2022 | 22 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2009 | 1456 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2004 | 276 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2004 | 220 | 0.050 |
Why?
|
Surveys and Questionnaires | 2 | 2014 | 2495 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 2759 | 0.050 |
Why?
|
Young Adult | 2 | 2013 | 5961 | 0.050 |
Why?
|
Prodrugs | 1 | 2022 | 46 | 0.050 |
Why?
|
Observer Variation | 1 | 2003 | 601 | 0.050 |
Why?
|
Reference Values | 2 | 2016 | 673 | 0.050 |
Why?
|
Delayed-Action Preparations | 1 | 2022 | 116 | 0.050 |
Why?
|
Placebos | 1 | 2022 | 218 | 0.050 |
Why?
|
Estrogen Receptor Modulators | 1 | 2001 | 10 | 0.050 |
Why?
|
Calcitonin | 1 | 2001 | 38 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2021 | 155 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2001 | 45 | 0.050 |
Why?
|
Diphosphonates | 1 | 2001 | 36 | 0.050 |
Why?
|
Calcifediol | 1 | 2020 | 21 | 0.050 |
Why?
|
Patient Reported Outcome Measures | 1 | 2022 | 165 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 73 | 0.050 |
Why?
|
Vitamins | 1 | 2020 | 81 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2022 | 916 | 0.050 |
Why?
|
Forecasting | 1 | 2001 | 303 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2003 | 579 | 0.040 |
Why?
|
Hypercalcemia | 1 | 2017 | 59 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2004 | 1194 | 0.040 |
Why?
|
Betacoronavirus | 1 | 2020 | 258 | 0.040 |
Why?
|
Europe | 1 | 2017 | 308 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2017 | 128 | 0.040 |
Why?
|
Symptom Assessment | 1 | 2016 | 65 | 0.030 |
Why?
|
Animals | 4 | 2009 | 26518 | 0.030 |
Why?
|
Calcium Citrate | 1 | 2013 | 2 | 0.030 |
Why?
|
Spasm | 1 | 2013 | 16 | 0.030 |
Why?
|
Back Pain | 1 | 2013 | 42 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2013 | 117 | 0.030 |
Why?
|
Hand Strength | 1 | 2013 | 51 | 0.030 |
Why?
|
Headache | 1 | 2013 | 73 | 0.030 |
Why?
|
Adolescent | 3 | 2013 | 8968 | 0.030 |
Why?
|
Prospective Studies | 1 | 2021 | 4194 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 893 | 0.020 |
Why?
|
Models, Statistical | 1 | 2014 | 574 | 0.020 |
Why?
|
Smoking | 1 | 2013 | 605 | 0.020 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2009 | 23 | 0.020 |
Why?
|
PPAR gamma | 1 | 2009 | 66 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2009 | 234 | 0.020 |
Why?
|
Hematocrit | 1 | 1988 | 68 | 0.020 |
Why?
|
Urea | 1 | 1988 | 57 | 0.020 |
Why?
|
Arginine Vasopressin | 1 | 1988 | 47 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 1988 | 167 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1988 | 181 | 0.020 |
Why?
|
Cell Lineage | 1 | 2009 | 273 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 183 | 0.020 |
Why?
|
Progesterone | 1 | 1988 | 107 | 0.020 |
Why?
|
Time Factors | 1 | 2016 | 5198 | 0.020 |
Why?
|
Blood Proteins | 1 | 1988 | 144 | 0.020 |
Why?
|
Inappropriate ADH Syndrome | 1 | 1987 | 5 | 0.020 |
Why?
|
Mice, Nude | 1 | 2009 | 790 | 0.020 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1987 | 27 | 0.020 |
Why?
|
Hyponatremia | 1 | 1987 | 25 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1987 | 86 | 0.020 |
Why?
|
Sodium | 1 | 1988 | 340 | 0.020 |
Why?
|
Body Weight | 1 | 1988 | 459 | 0.020 |
Why?
|
Child | 2 | 2008 | 6913 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2016 | 2183 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2009 | 1918 | 0.020 |
Why?
|
Lod Score | 1 | 2004 | 152 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2004 | 117 | 0.020 |
Why?
|
CHO Cells | 1 | 2004 | 187 | 0.020 |
Why?
|
Radiometry | 1 | 2004 | 53 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2004 | 290 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 416 | 0.010 |
Why?
|
Cricetinae | 1 | 2004 | 560 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 646 | 0.010 |
Why?
|
Mice | 2 | 2009 | 11313 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2004 | 250 | 0.010 |
Why?
|
Blood Pressure | 1 | 1988 | 1143 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2004 | 623 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 895 | 0.010 |
Why?
|
Pedigree | 1 | 2004 | 966 | 0.010 |
Why?
|
Infant | 1 | 1988 | 3036 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2004 | 1074 | 0.010 |
Why?
|
Child, Preschool | 1 | 1988 | 3608 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 2062 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 3029 | 0.010 |
Why?
|